sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Sat Dec 13
Where Will Nike Be in 5 Years?
2d
Y
Is Rigetti Computing Stock a Buy or Sell After a Director Dumped Shares Worth $1.3 Million?
2d
Y
3 Types of Cryptocurrencies That Can Diversify a Tech-Heavy Portfolio
2d
Y
Cathie Wood Invest Dumps Over $10 Million Of Palantir Stock Amid Talk Of 'Cramer Curse' — Buys This Hot AI Stock Instead
2d
Y
Cardano Stalls at Breakout Point: Holder Shifts Now Weaken The 50% Rally Hope
2d
Y
GQRE vs. REET: The Rising ETF Against the Largest Global Real Estate ETF
2d
Y
As Meta Delays New Ray-Ban Display Glasses, Should You Buy, Sell, or Hold META Stock?
2d
Y
SOXX Delivered Larger Gains Than XLK, but With Greater Risk and Volatility
2d
Y
President Sells 25,000 EverCommerce Shares for $250,000
2d
Y
'There Could Be A Whole Other Life He's Living' 'The Ramsey Show' Host Says After Wife Finds $209K Debt Behind Her Back
2d
Y
Why Ubiquiti Rallied 67% in 2025
2d
Y
More Bonds Are Teetering on the Brink of Junk: Credit Weekly
2d
Y
I'm thinking of forgoing health insurance in 2026 because I can barely afford it. What are my options?
2d
Y
Here’s What Analysts Think About Biogen Inc. (BIIB)
2d
Y
AbbVie Inc. (ABBV) Gets Downgraded to Peer Perform From Outperform by Wolfe Research
2d
Y
Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) – Here’s Why
2d
Y
Eli Lilly and Company (LLY) to Acquire Ventyx Biosciences
2d
Y
Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here’s Why
2d
Y
Amarin Corporation (AMRN) Announces Select Unaudited Financial Highlights
2d
Y
Truist Lifts PT on Teva Pharmaceutical Industries (TEVA) to $36 From $32
2d
Y
Truist Raises PT on Amneal Pharmaceuticals (AMRX) to $15 From $14
2d
Y
Indivior PLC (INDV) Announces Full-Year 2026 Financial Guidance
2d
Y
Amylyx Pharmaceuticals (AMLX) Announces the Selection of AMX0318 as Development Candidate for PBH and Other Rare Diseases
2d
Y
Jim Cramer on AeroVironment: “That’s a Terrific Company”
2d
Y
Jim Cramer on Procter & Gamble: “It Has the Opportunity to Shake Things Up”
2d
Y
Jim Cramer on Microsoft: “Stock’s Been Punished By the Fact That Management Wants to Spend a Fortune on AI”
2d
Y
Jim Cramer Discusses CrowdStrike After Jensen Huang’s Endorsement
2d
Y
Jim Cramer on JPMorgan: “You Wait for the Reaction to Jamie’s Cautious Commentary to Give You a Better Entry Point”
2d
Y
Can Chevron Stock Hit $205 in 2026?
2d
Y
Most People Buy Mansions But This Virginia Lottery Winner Took the Lump Sum From a $348 Million Jackpot and Bought a Zero-Turn Lawn Mower Instead
2d
Y
3 Reasons Small-Cap Stocks Could Outperform in 2026 -- and 1 Fund to Buy Now
2d
Y
Vistra Wins Mega Nuclear Deal With Meta, Stock Jumps
2d
Y
Jim Cramer on Wingstop: “I Can’t Pound the Table When We Still Have Too High Food Inflation”
2d
Y
Jim Cramer on Rambus: “It’s Not That Expensive Versus Growth”
2d
Y
Jim Cramer on Nebius: “The Opportunities Are Better Elsewhere”
2d
Y
Jim Cramer on Palo Alto: “I Think It Is a Buy”
2d
Y
Jim Cramer Says He “Wouldn’t Mind a Speculative Position Only on Roblox”
2d
Y
Jim Cramer Medline: “It’s a Terrific Company”
2d
Y
Jim Cramer Says “Fermi’s More of a Business Plan Than a Business”
2d
Y
Jim Cramer Discusses CoreWeave’s IPO Surge and Pullback
2d
Y
Jim Cramer on Circle Internet: “On Paper, This One’s a Standout”
2d
Y
Jim Cramer on Celsius Holdings: “The Company’s Doing Quite Well”
2d
Y
Is BellRing Brands (BRBR) One of the Oversold Stocks to Buy Now?
2d
Y
Bernstein Gives Coinbase (COIN) an Outperform Rating Amid Tokenization Supercycle Outlook
2d
Y
Raymond James Upgrades WaterBridge Infrastructure (WBI) to Strong Buy Following Midstream Sector Rating Adjustments
2d
Y
Morgan Stanley Views Doximity (DOCS) Underperformance as Attractive Entry Point Amid Strong Engagement
2d
Y
BMO Capital Maintains Positive Long-Term Outlook for Vital Farms (VITL) Despite Temporary 2025 Revision
2d
Y
Roth Capital Notes Unexpected Cancellation of ReNew Energy (RNW) Take-Private Deal Following Masdar Withdrawal
2d
Y
BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60
2d
Y
Freedom Capital Highlights Gambling.com (GAMB) as Capital-Light Opportunity to Leverage US Market Legalization
2d
Y
More →